-transparent.png){kind=logo}
New therapeutic schemes have been proposed recently for treatment of rheumatoid arthritis. Among these, methotrexate at low doses is recommended as basic therapy, already shortly after the diagnosis is established. We report on a 68-year-old female with rheumatoid arthritis who developed bilateral pneumocystis-carinii pneumonia with a lethal course and bilateral sinusitis maxillaris with candida lusitaniae. Various opportunistic infections have been described in the literature after low-dose methotrexate. It is our view that the use of methotrexate in rheumatoid arthritis should still be considered cautiously until further data on the risk-benefit ratio of long-term use become available.
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
June 1996,
Ryumachi. [Rheumatism],
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
March 1991,
Thorax,
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
January 1992,
Thorax,
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
August 1991,
The Journal of rheumatology,
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
January 1994,
Scandinavian journal of rheumatology,
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
October 1983,
Arthritis and rheumatism,
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
August 1995,
Ryumachi. [Rheumatism],
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
August 1991,
The Journal of rheumatology,
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
June 1993,
Clinical rheumatology,
E Wyss, and
M Kuhn, and
H P Luzi, and
W H Reinhart
June 2004,
Arerugi = [Allergy],
